Differential Risks for Melanoma: p16 and DNA Repair

CompletedOBSERVATIONAL
Enrollment

323

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
MelanomaSkin Melanoma
Interventions
OTHER

self-administered questionnaire and blood draw

Epidemiologic data will be collected via a self-administered questionnaire which will be distributed to subjects by a member of the study staff. It should take less than fifteen minutes to complete, and subjects will have the options of completing it at the time of their blood-drawing or filling it out at home and mailing it back to the study staff.

OTHER

self-administered questionnaire and blood draw

Epidemiologic data will be collected via a self-administered questionnaire which will be distributed to subjects by a member of the study staff. It should take less than fifteen minutes to complete, and subjects will have the options of completing it at the time of their blood-drawing or filling it out at home and mailing it back to the study staff.

OTHER

health questionnaire, blood draw and skin exam

Numbers will be randomly selected from a pool of prefixes. Numbers will be screened by computer for being working, non-business, non-fax, and non-modem numbers. After establishing eligibility for the study, we will send the potential control a letter further explaining the purpose of the study and its requirements. An interviewer will then call to arrange an appointment. During the interview, the subject will sign informed consent, be given the public health questionnaire, have 30 ml of blood drawn, and undergo the skin examination of arms and back.

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

University of New Mexico

OTHER

collaborator

Yale University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00615095 - Differential Risks for Melanoma: p16 and DNA Repair | Biotech Hunter | Biotech Hunter